Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Kirsten Anderson
Senior Coordinator, Regulatory
Az Health Sciences Division
Full Page
Overview
Research
More
Collaboration
(44)
C. Kent Kwoh
Mutual work: 6 Proposals﹒4 Grants
Collaboration Details
Franz Rischard
Mutual work: 7 Grants﹒8 Proposals
Collaboration Details
Fayez Ghishan
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Scott Sherman
Mutual work: 6 Proposals﹒6 Grants
Collaboration Details
Cori Daines
Mutual work: 2 Proposals﹒1 Grant
Collaboration Details
Page 1 of 9
Previous page
Next page
Grants
(59)
A Phase I/II, Randomized, Double-blind, Sham Control Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Ascending Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gen
Active
·
2024
·
$0 / $1.1M
·
External
gene therapy,
neurodegenerative diseases,
clinical trial,
genetic disorders,
drug safety
A Phase Ill, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of a Single Administration Of Comp360 in Participants With Treatment-
Active
·
2024
·
$0 / $994.4K
·
External
clinical trials,
pharmacology,
mental health,
neuroscience,
psychiatry
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have
Active
·
2024
·
$0 / $964K
·
External
clinical trials,
dermatology,
immunology,
inflammatory diseases,
pharmacology
Study to Evaluate Safety, Efficacy and Tolerability of ABBV-950 for the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
Active
·
2024
·
$0 / $822.1K
·
External
stroke rehabilitation,
spasticity treatment,
drug safety,
efficacy evaluation,
tolerability assessment
A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hyp
Active
·
2024
·
$0 / $555.7K
·
External
clinical trials,
pulmonary arterial hypertension,
drug efficacy,
safety evaluation,
combination treatment
Page 1 of 12
Previous page
Next page
